Acrobiosystems Co Ltd Class A 301080
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥74.44
- Day Range
- CN¥72.00–75.98
- 52-Week Range
- CN¥35.87–141.99
- Bid/Ask
- CN¥74.20 / CN¥74.21
- Shares Outstanding
- 167.68M
- Market Cap
- CN¥12.44B
- Volume/Avg
- 9M / 16M
Key Statistics
- Price/Earnings (Normalized)
- 59.91
- Price/Sales
- 12.15
- Dividend Yield (Trailing)
- 0.81%
- Dividend Yield (Forward)
- 0.81%
- Dividend Payment Schedule
- Jun
- Total Yield
- 0.81%
Company Profile
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 926
Valuation
Metric | 301080 |
|---|---|
Price/Earnings (Normalized) | 59.91 |
Price/Book Value | 4.55 |
Price/Sales | 12.15 |
Price/Cash Flow | 37.00 |
Price/Earnings
301080
Financial Strength
Metric | 301080 |
|---|---|
Quick Ratio | 7.26 |
Current Ratio | 8.96 |
Interest Coverage | 733.29 |
Quick Ratio
301080
Profitability
Metric | 301080 |
|---|---|
Return on Assets (Normalized) | 5.77% |
Return on Equity (Normalized) | 6.49% |
Return on Invested Capital (Normalized) | 5.07% |
Return on Assets
301080
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|Rgh>?G> | LOCK|^@RX@ | $135B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|KG^Z%<! | LOCK|P!jK? | $99B | |||
| Moderna Inc MRNA | LOCK|@dK^&C | LOCK|#d> | $84B | |||
| argenx SE ADR ARGX | LOCK|#DS<rL | LOCK|Xk | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|&^g?&DY | LOCK|$xv | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|!?$&Ng$ | LOCK|P^Mg | $31B | |||
| Incyte Corp INCY | LOCK|ygZSxsg | LOCK|pbs | $24B | |||
| BioNTech SE ADR BNTX | LOCK|D@<Hb## | LOCK|^k | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|&>J>>H | LOCK|QTW& | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|%<NrPlV | LOCK|Qn< | $15B |